NM-23 Hi immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer
1996

Nm23-H1 Protein in Colorectal Cancer

Sample size: 202 publication Evidence: low

Author Information

Author(s): G Lindmark

Primary Institution: Department of Medical and Physiological Chemistry, Biomedical Center, University of Uppsala; Department of Surgery, University Hospital, University of Umea

Hypothesis

Is immunohistochemical staining for nm23-H1 protein in the primary tumour correlated with tumour characteristics and patient survival in colorectal cancer?

Conclusion

The study found that nm23-H1 staining patterns do not correlate with tumour stage, differentiation, or patient survival in colorectal cancer.

Supporting Evidence

  • Nm23-H1-negative tumours were less differentiated than those with strong or moderate staining.
  • A higher number of nm23-H1-negative tumours were near-diploid compared to those expressing nm23-H1.
  • No correlation was found between nm23-H1 staining patterns and patient survival time.

Takeaway

This study looked at a protein called nm23-H1 in colorectal cancer to see if it could help predict how serious the cancer is, but it turned out not to be helpful.

Methodology

Immunohistochemical staining of nm23-H1 protein was performed on colorectal cancer biopsies, and correlations with tumour characteristics and patient survival were analyzed.

Limitations

The study did not find significant correlations between nm23-H1 expression and important clinical outcomes, suggesting limited clinical utility.

Participant Demographics

The study included 202 colorectal cancer patients, with 117 women and 85 men, and a mean age of 71 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication